Tempest Therapeutics, Inc. (TPST) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2013: $02014: $02015: $2.25M2016: $5.40M2017: $790.0K$790.0K
2013Cost of Revenue (USD)2017
Fiscal YearCost of RevenueChange YoY
2017$790.0K-85.4%
2016$5.40M+140.2%
2015$2.25M
2014$0
2013$0